{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.12.1044",
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "2.16.840.1.113883.3.464.1003.110.12.1044"
  } ],
  "version": "20170504",
  "name": "InfluenzaVaccineAdministered",
  "title": "Influenza Vaccine Administered",
  "status": "active",
  "experimental": false,
  "publisher": "NLM",
  "expansion": {
    "identifier": "20220505",
    "timestamp": "2022-08-16T11:47:48-06:00",
    "contains": [ {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90655",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90657",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90661",
      "display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90662",
      "display": "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90673",
      "display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90674",
      "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90685",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90686",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90687",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90688",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90756",
      "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "786847005",
      "display": "Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "86198006",
      "display": "Administration of vaccine product containing only Influenza virus antigen (procedure)"
    } ]
  }
}